Newsfeeds Archive - Spark Newswire

4 minute read

Numinus Wellness Q2 2024 Revenue Declines Amid Clinic Reshuffling And Expected Industry Trends

April 15, 4:13 PM

Psychedelics healthcare company Numinus Wellness (OTCQX:NUMIF) shared its unaudited, condensed and consolidated interim financial results for the three…

NUMIF

3 minute read

Two Top Biotechs Forge MDMA Supply Deals For An Expanding Research Field

By Lara Goldstein

March 26, 3:35 PM

Two separate deals hit the wires on Tuesday. One is PharmAla Biotech’s (OTC:OPTHF) with Tel Aviv University for…

MDXXF

4 minute read

Psyched: Psychedelics & Sex, MDMA And Federal Approval, Canadians For End-Of-Life Care And More

By Lara Goldstein

February 15, 9:36 AM

Can Psychedelics Increase Sexual Interest And Satisfaction? Study Says Yes And Effects Can Last Months A new study…

ATAI

4 minute read

Psyched: Suggestibility And Psychedelics’ Effects, EU’s $7M Research Fund, Australia’s Treatment Delivery, BZ Podcast And More

By Lara Goldstein

January 27, 11:00 AM

New study finds suggestibility plays a role in antidepressant effects of psilocybin therapy. EU invests 6.5M euros in psychedelics for pulmonary disorder, MS, ALS, and Parkinson's. Australian psychiatrists provide first psychedelic-assisted treatments in 50 years.

ATAI

3 minute read

Numinus Wellness Continues Tight Expense Management With Strategic Reviews Underway

By Lara Goldstein

January 18, 11:00 AM

Psychedelics mental healthcare company Numinus Wellness (OTCQX: NUMIF) posted its financial results for the three months ended Nov. 30, 2023. Q1 numbers show:

NUMIF

9 minute read

30 Psychedelics Executives, Scientists & Influencers To Watch In 2024 And Beyond

By Lara Goldstein

January 10, 8:56 PM

The emerging psychedelics industry is expanding rapidly across the globe. With research demonstrating promising therapeutic potential for substances like psilocybin and MDMA to treat mental health conditions, this sector has attracted growing attention and investment.

CYBN